Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2017 | 07-2016 | 07-2015 | 07-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,873 | 1,481 | 434 | 255 | N/A |
| Receivables | 3,750 | 313 | N/A | N/A | 0 |
| TOTAL | $10,787 | $1,856 | $467 | $279 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3 | 7 | N/A | N/A | 0 |
| Intangibles | 18 | 19 | 20 | 22 | 0 |
| TOTAL | $20 | $26 | $20 | $22 | $N/A |
| Total Assets | $10,808 | $1,882 | $488 | $301 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 130 | 350 | N/A |
| Accounts payable and accrued liabilities | 2,212 | 141 | 316 | 201 | 0 |
| Accrued Expenses | 1,701 | 3,681 | 3,129 | 1,417 | N/A |
| TOTAL | $4,167 | $4,237 | $3,575 | $1,967 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 254 | 250 | N/A | N/A | N/A |
| TOTAL | $2,307 | $2,350 | $5,300 | $1,412 | $N/A |
| Total Liabilities | $6,474 | $6,587 | $8,875 | $3,379 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 2 | 2 | 2 | 2 | N/A |
| Retained earnings | -54,605 | -61,185 | -53,371 | -46,333 | N/A |
| TOTAL | $4,334 | $-4,705 | $-8,387 | $-3,078 | $N/A |
| Total Liabilities And Equity | $10,808 | $1,882 | $488 | $301 | $0 |